SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001567619-15-001461
Filing Date
2015-11-05
Accepted
2015-11-05 16:05:22
Documents
4
Period of Report
2015-10-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K s001093x1_8k.htm 8-K 23313
2 EXHIBIT 10.1 s001093x1_ex10-1.htm EX-10.1 80721
3 EXHIBIT 99.1 s001093x1_ex99-1.htm EX-99.1 9126
4 GRAPHIC s001093x1_image.gif GRAPHIC 4479
  Complete submission text file 0001567619-15-001461.txt   120758
Mailing Address 200 CONNELL DRIVE SUITE 1600 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1600 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37568 | Film No.: 151200568
SIC: 2834 Pharmaceutical Preparations